Related Experiment Video
Updated: Jul 11, 2025
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.7K
[Personalized approach to anaplastic thyroid carcinoma].
Sabine Wächter1, Detlef K Bartsch2, Elisabeth Maurer2
1Klinik für Visceral‑, Thorax- und Gefäßchirurgie, Philipps-Universität Marburg, Baldingerstraße, 35043, Marburg, Deutschland. seckhard@med.uni-marburg.de.
Chirurgie (Heidelberg, Germany)
|November 16, 2023
Summary
Personalized therapies targeting tumor mutations are emerging for anaplastic thyroid carcinoma (ATC). Neoadjuvant molecular treatments may improve surgical outcomes for advanced ATC, offering new hope for this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Anaplastic thyroid carcinoma (ATC) is a rare and aggressive thyroid malignancy.
- Current multimodal treatments (surgery, radiation, chemotherapy) offer a poor prognosis for advanced ATC.
- Personalized medicine is revolutionizing ATC treatment by targeting specific tumor mutations.
Purpose:
- To provide an overview of current molecular-based and personalized treatment options for ATC.
- To highlight the potential of targeted therapies and combination treatments.
- To discuss the role of neoadjuvant therapy in improving surgical resectability and patient outcomes.
Summary:
- Advanced ATC often presents with poor prognosis despite conventional therapies.
- Molecular-based treatments, including BRAFV600E and multikinase inhibitors, are showing promise.
- Combination therapy with immune checkpoint inhibitors is being explored, particularly in neoadjuvant settings.
- Neoadjuvant molecular therapies may convert unresectable ATC to a resectable state, potentially altering surgical paradigms.
Impact:
- Individualized, molecular-based therapies are expected to be the future of ATC treatment.
- Neoadjuvant approaches could significantly improve the resectability and prognosis of locally advanced and metastatic ATC.
- Further prospective studies are needed to validate the efficacy of these novel combination therapies.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530